Stock listing

Nextcell Pharma Ab

Selected listing: NXTCL · OMXSTO · SEK · SE

Nextcell Pharma Ab (Stockholm:NXTCL), Health Technology. Latest release Jan 21, 2026: NextCell decides to propose a directed share issue of SEK 15 million.

NXTCL:OMXSTOSEKSEUpdated October 3, 2026
Nextcell Pharma Ab logo
Ticker
Stockholm:NXTCL
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Stockholm
Currency
SEK

About Nextcell Pharma Ab

Nextcell Pharma Ab is a public company listed on the Swedish market under the ticker NXTCL. Nextcell Pharma is focused on developing innovative therapies in the pharmaceutical sector.

Latest news from Nextcell Pharma Ab

NextCell decides to propose a directed share issue of SEK 15 million

January 21, 2026

NextCell Pharma appoints Eric Gustafsson as new CFO

November 20, 2025

NextCell Pharma AB announces CFO transition

September 18, 2025

All Nextcell Pharma Ab news →

Research Nextcell Pharma Ab

Nextcell Pharma Ab company profile

View the public company page for Nextcell Pharma Ab on 6ix.

Nextcell Pharma Ab news

Read company news and market updates connected to Nextcell Pharma Ab.

Nextcell Pharma Ab investor events

Find investor webinars, events, and replay context for Nextcell Pharma Ab.

Alternate listings

65G:FWB

DE · EUR

Alternate listing for Nextcell Pharma Ab; the primary context on this page is NXTCL:OMXSTO.